NA Fecal Occult Blood Tests Market - Industry Trends and Forecast to 2030

TABLE OF CONTENTS

1 INTRODUCTION 74

• 1.1 OBJECTIVES OF THE STUDY 74
• 1.2 MARKET DEFINITION 74
• 1.3 OVERVIEW OF THE NORTH AMERICA FECAL OCCULT BLOOD TESTS MARKET 74
• 1.4 CURRENCY AND PRICING 76
• 1.5 LIMITATIONS 76
• 1.6 MARKETS COVERED 76

2 MARKET SEGMENTATION 80

• 2.1 MARKETS COVERED 80
• 2.2 GEOGRAPHICAL SCOPE 81
• 2.3 YEARS CONSIDERED FOR THE STUDY 82
• 2.4 DBMR TRIPOD DATA VALIDATION MODEL 83
• 2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 86
• 2.6 MULTIVARIATE MODELLING 87
• 2.7 PRODUCT TYPE SEGMENT LIFELINE CURVE 87
• 2.8 MARKET APPLICATION COVERAGE GRID 88
• 2.9 DBMR MARKET POSITION GRID 89
• 2.10 VENDOR SHARE ANALYSIS 90
• 2.11 SECONDARY SOURCES 91
• 2.12 ASSUMPTIONS 91

3 EXECUTIVE SUMMARY 92

4 PREMIUM INSIGHTS 94

• 4.1 PESTEL ANALYSIS 95
• 4.2 PORTER'S 5 FORCES 96

5 INDUSTRY INSIGHTS 97

6 REGULATORY FRAMEWORK 99

• 6.1 REGULATORY SCENARIO BY U.S. FDA 99
• 6.2 REGULATORY SCENARIO IN U.S. 99
• 6.3 REGULATORY SCENARIO IN EUROPE 100
• 6.4 REGULATORY SCENARIO IN CANADA 100
• 6.5 REGULATORY SCENARIO IN AUSTRALIA 100

7 MARKET OVERVIEW 101

• 7.1 DRIVERS 103
  • 7.1.1 RISING CASES OF COLORECTAL CANCER NORTH AMERICALY 103
  • 7.1.2 DEVELOPMENT OF DIRECT-TO-CONSUMER LABORATORY TESTING 103
  • 7.1.3 EASY AVAILABILITY OF FECAL OCCULT IMMUNOLOGICAL TEST DEVICES IN ONLINE STORES 104
  • 7.1.4 INCREASING INCLINATION TOWARDS POINT-OF-CARE DIAGNOSTICS 104
• 7.2 RESTRAINTS 104
  • 7.2.1 CHANGE IN CONSUMER PREFERENCE TOWARDS COST-EFFECTIVE ALTERNATIVES 104
  • 7.2.2 LOW AWARENESS ABOUT FECAL OCCULT BLOOD TESTS IN UNDEVELOPED COUNTRIES 105
• 7.3 OPPORTUNITIES 105
  • 7.3.1 INCREASE IN SCREENING PROCEDURES 105
  • 7.3.2 RISING TECHNICAL ADVANCEMENTS 106
  • 7.3.3 STRATEGIC INITIATIVES 106
• 7.4 CHALLENGES 107
  • 7.4.1 LACK OF SKILLED PROFESSIONALS 107
  • 7.4.2 LOW EFFICIENCY 107

8 NORTH AMERICA FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE 108

• 8.1 OVERVIEW 109
• 8.2 LATERAL FLOW IMMUNO-FOB TEST KITS 112
• 8.3 IMMUNO-FOB AGGLUTINATION TEST KITS 112
• 8.4 IMMUNO-FOB ELISA TEST KITS 113
• 8.5 GUAIAC FOB STOOL TEST 114
  • 8.5.1 KITS 115
    • 8.5.1.1 GUAIAC SLIDES 115
      • 8.5.1.1.1 25 PACKAGE 115
      • 8.5.1.1.2 20 PACKAGE 115
      • 8.5.1.1.3 OTHERS 115
    • 8.5.1.2 ALPHA GUAIACONIC ACID (GUAIAC) IMPREGNATED PAPER 116
      • 8.5.1.2.1 SENSITIVITY IS 50NG/ML 116
      • 8.5.1.2.1.1 25 PACKAGE 116
      • 8.5.1.2.1.2 20 PACKAGE 116
      • 8.5.1.2.1.3 OTHERS 117
      • 8.5.1.2.2 SENSITIVITY IS 75NG/ML 117
      • 8.5.1.2.2.1 25 PACKAGE 117
      • 8.5.1.2.2.2 20 PACKAGE 117
      • 8.5.1.2.2.3 OTHERS 117
      • 8.5.1.2.3 OTHERS 117
    • 8.5.1.3 OTHERS 118
  • 8.5.2 REAGENTS 118
    • 8.5.2.1 HYDROGEN PEROXIDE 118
    • 8.5.2.2 OTHERS 118
• 8.6 FLUSHABLE REAGENT PAD OR TISSUE 118
• 8.7 OTHERS 119

9 NORTH AMERICA FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION 120

• 9.1 OVERVIEW 121
• 9.2 COLORECTAL CANCER SCREENING 124
  • 9.2.1 LATERAL FLOW IMMUNO-FOB TEST KITS 125
  • 9.2.2 IMMUNO-FOB AGGLUTINATION TEST KITS 125
  • 9.2.3 IMMUNO-FOB ELISA TEST KITS 125
  • 9.2.4 GUAIAC FOB STOOL TEST 125
  • 9.2.5 FLUSHABLE REAGENT PAD OR TISSUE 125
  • 9.2.6 OTHERS 125
• 9.3 CONCERN FOR GASTROINTESTINAL BLEEDING 125
  • 9.3.1 LATERAL FLOW IMMUNO-FOB TEST KITS 126
  • 9.3.2 IMMUNO-FOB AGGLUTINATION TEST KITS 126
  • 9.3.3 IMMUNO-FOB ELISA TEST KITS 126
  • 9.3.4 GUAIAC FOB STOOL TEST 127
  • 9.3.5 FLUSHABLE REAGENT PAD OR TISSUE 127
  • 9.3.6 OTHERS 127
• 9.4 POLYPS 127
  • 9.4.1 LATERAL FLOW IMMUNO-FOB TEST KITS 128
  • 9.4.2 IMMUNO-FOB AGGLUTINATION TEST KITS 128
  • 9.4.3 IMMUNO-FOB ELISA TEST KITS 128
  • 9.4.4 GUAIAC FOB STOOL TEST 128
  • 9.4.5 FLUSHABLE REAGENT PAD OR TISSUE 128
  • 9.4.6 OTHERS 128
• 9.5 DIVERTICULOSIS 129
  • 9.5.1 LATERAL FLOW IMMUNO-FOB TEST KITS 130
  • 9.5.2 IMMUNO-FOB AGGLUTINATION TEST KITS 130
  • 9.5.3 IMMUNO-FOB ELISA TEST KITS 130
  • 9.5.4 GUAIAC FOB STOOL TEST 130
  • 9.5.5 FLUSHABLE REAGENT PAD OR TISSUE 130
  • 9.5.6 OTHERS 130
• 9.6 ULCERS 130
  • 9.6.1 LATERAL FLOW IMMUNO-FOB TEST KITS 131
  • 9.6.2 IMMUNO-FOB AGGLUTINATION TEST KITS 131
  • 9.6.3 IMMUNO-FOB ELISA TEST KITS 131
  • 9.6.4 GUAIAC FOB STOOL TEST 132
  • 9.6.5 FLUSHABLE REAGENT PAD OR TISSUE 132
  • 9.6.6 OTHERS 132
• 9.7 HAEMORRHOIDS 132
  • 9.7.1 LATERAL FLOW IMMUNO-FOB TEST KITS 133
  • 9.7.2 IMMUNO-FOB AGGLUTINATION TEST KITS 133
  • 9.7.3 IMMUNO-FOB ELISA TEST KITS 133
  • 9.7.4 GUAIAC FOB STOOL TEST 133
  • 9.7.5 FLUSHABLE REAGENT PAD OR TISSUE 133
  • 9.7.6 OTHERS 133
• 9.8 COLITIS 134
  • 9.8.1 LATERAL FLOW IMMUNO-FOB TEST KITS 135
  • 9.8.2 IMMUNO-FOB AGGLUTINATION TEST KITS 135
  • 9.8.3 IMMUNO-FOB ELISA TEST KITS 135
  • 9.8.4 GUAIAC FOB STOOL TEST 135
  • 9.8.5 FLUSHABLE REAGENT PAD OR TISSUE 135
  • 9.8.6 OTHERS 135
• 9.9 ANEMIA 135
  • 9.9.1 LATERAL FLOW IMMUNO-FOB TEST KITS 136
  • 9.9.2 IMMUNO-FOB AGGLUTINATION TEST KITS 136
  • 9.9.3 IMMUNO-FOB ELISA TEST KITS 136
  • 9.9.4 GUAIAC FOB STOOL TEST 137
  • 9.9.5 FLUSHABLE REAGENT PAD OR TISSUE 137
  • 9.9.6 OTHERS 137
• 9.10 OTHERS 137

10 NORTH AMERICA FECAL OCCULT BLOOD TESTS MARKET, BY END USER 138

• 10.1 OVERVIEW 139
• 10.2 DIAGNOSTIC LABORATORIES 142
• 10.3 HOSPITALS 142
• 10.4 SPECIALITY CLINICS 143
• 10.5 OTHERS 144

11 NORTH AMERICA FECAL OCCULT BLOOD TESTS MARKET, BY DISTRIBUTION CHANNEL 145

• 11.1 OVERVIEW 146
• 11.2 DIRECT TENDER 149
• 11.3 RETAIL SALE 149
• 11.4 E-COMMERCE 150
• 11.5 OTHERS 151

12 NORTH AMERICA FECAL OCCULT BLOOD TESTS MARKET, BY REGION 152

• 12.1 NORTH AMERICA 153
  • 12.1.1 U.S. 166
  • 12.1.2 CANADA 174
  • 12.1.3 MEXICO 182

13 NORTH AMERICA FECAL OCCULT BLOOD TESTS MARKET: COMPANY LANDSCAPE 190

• 13.1 COMPANY SHARE ANALYSIS: NORTH AMERICA 190

14 SWOT ANALYSIS 191

15 COMPANY PROFILE 192

• 15.1 QUIDEL CORPORATION 192
  • 15.1.1 COMPANY SNAPSHOT 192
  • 15.1.2 REVENUE ANALYSIS 192
  • 15.1.3 COMPANY SHARE ANALYSIS 193
  • 15.1.4 PRODUCT PORTFOLIO 193
  • 15.1.5 RECENT DEVELOPMENT 193
• 15.2 WONDFO. 194
  • 15.2.1 COMPANY SNAPSHOT 194
  • 15.2.2 COMPANY SHARE ANALYSIS 194
  • 15.2.3 PRODUCT PORTFOLIO 195
  • 15.2.4 RECENT DEVELOPMENT 195
• 15.3 SIEMENS HEALTHCARE GMBH 196
  • 15.3.1 COMPANY SNAPSHOT 196
  • 15.3.2 REVENUE ANALYSIS 196
  • 15.3.3 COMPANY SHARE ANALYSIS 197
  • 15.3.4 RODUCT PORTFOLIO 197
  • 15.3.5 RECENT DEVELOPMENT 197
• 15.4 EIKEN CHEMICAL CO., LTD. 198
  • 15.4.1 COMPANY SNAPSHOT 198
  • 15.4.2 REVENUE ANALYSIS 198
  • 15.4.3 COMPANY SHARE ANALYSIS 199
  • 15.4.4 PRODUCT PORTFOLIO 199
  • 15.4.5 RECENT DEVELOPMENT 199
• 15.5 BIOHIT OYJ 200
  • 15.5.1 COMPANY SNAPSHOT 200
  • 15.5.2 REVENUE ANALYSIS 200
  • 15.5.3 COMPANY SHARE ANALYSIS 201
  • 15.5.4 PRODUCT PORTFOLIO 201
  • 15.5.5 RECENT DEVELOPMENT 201
• 15.6 ACCUBIOTECH CO LTD 202
  • 15.6.1 COMPANY SNAPSHOT 202
  • 15.6.2 PRODUCT PORTFOLIO 202
  • 15.6.3 RECENT DEVELOPMENT 202
• 15.7 ACCUQUIK TEST KITS 203
  • 15.7.1 COMPANY SNAPSHOT 203
  • 15.7.2 PRODUCT PORTFOLIO 203
  • 15.7.3 RECENT DEVELOPMENT 203
• 15.8 AIDIAN 204
  • 15.8.1 COMPANY PROFILE 204
  • 15.8.2 PRODUCT PORTFOLIO 204
  • 15.8.3 RECENT DEVELOPMENT 204
• 15.9 ALFA SCIENTIFIC DESIGNS, INC. 205
  • 15.9.1 COMPANY SNAPSHOT 205
  • 15.9.2 PRODUCT PORTFOLIO 205
  • 15.9.3 RECENT DEVELOPMENT 205
• 15.10 APACOR LIMITED 206
  • 15.10.1 COMPANY SNAPSHOT 206
  • 15.10.2 PRODUCT PORTFOLIO 206
  • 15.10.3 RECENT DEVELOPMENT 206
• 15.11 BIOPANDA REAGENTS LTD 207
  • 15.11.1 COMPANY SNAPSHOT 207
  • 15.11.2 PRODUCT PORTFOLIO 207
  • 15.11.3 RECENT DEVELOPMENT 207
• 15.12 BODITECH MED INC. 208
  • 15.12.1 COMPANY SNAPSHOT 208
  • 15.12.2 PRODUCT PORTFOLIO 208
  • 15.12.3 RECENT DEVELOPMENT 208
• 15.13 CENOGENICS CORPORATION 209
  • 15.13.1 COMPANY SNAPSHOT 209
  • 15.13.2 PRODUCT PORTFOLIO 209
  • 15.13.3 RECENT DEVELOPMENT 209
• 15.14 CERTEST BIOTEC. 210
  • 15.14.1 COMPANY SNAPSHOT 210
  • 15.14.2 PRODUCT PORTFOLIO 210
  • 15.14.3 RECENT DEVELOPMENT 210
• 15.15 CTK BIOTECH, INC. 211
  • 15.15.1 COMPANY SNAPSHOT 211
  • 15.15.2 PRODUCT PORTFOLIO 211
  • 15.15.3 RECENT DEVELOPMENT 211
• 15.16 EDP BIOTECH 212
  • 15.16.1 COMPANY SNAPSHOT 212
  • 15.16.2 PRODUCT PORTFOLIO 212
  • 15.16.3 1.16.3 RECENT DEVELOPMENT 212
• 15.17 EPITOPE DIAGNOSTICS, INC. 213
  • 15.17.1 COMPANY SNAPSHOT 213
  • 15.17.2 PRODUCT PORTFOLIO 213
  • 15.17.3 RECENT DEVELOPMENT 213
• 15.18 EUROLYSER DIAGNOSTICA GMBH 214
  • 15.18.1 COMPANY SNAPSHOT 214
  • 15.18.2 PRODUCT PORTFOLIO 214
  • 15.18.3 RECENT DEVELOPMENT 214
• 15.19 FIRSTEP 215
  • 15.19.1 COMPANY SNAPSHOT 215
  • 15.19.2 PRODUCT PORTFOLIO 215
  • 15.19.3 RECENT DEVELOPMENT 215
• 15.20 HANGZHOU CLONGENE BIOTECH CO., LTD 216
  • 15.20.1 COMPANY SNAPSHOT 216
  • 15.20.2 PRODUCT PORTFOLIO 216
  • 15.20.3 RECENT DEVELOPMENT 216
• 15.21 HUMASIS.COM 217
  • 15.21.1 COMPANY SNAPSHOT 217
  • 15.21.2 PRODUCT PORTFOLIO 217
  • 15.21.3 RECENT DEVELOPMENT 217
• 15.22 JANT PHARMACAL CORPORATION 218
  • 15.22.1 COMPANY SNAPSHOT 218
  • 15.22.2 PRODUCT PORTFOLIO 218
  • 15.22.3 RECENT DEVELOPMENT 218

• 15.23 PRIMA LAB SA 219
  • 15.23.1 COMPANY SNAPSHOT 219
  • 15.23.2 PRODUCT PORTFOLIO 219
  • 15.23.3 RECENT DEVELOPMENT 219
• 15.24 ULTI MED PRODUCTS (DEUTSCHLAND) GMBH 220
  • 15.24.1 COMPANY SNAPSHOT 220
  • 15.24.2 PRODUCT PORTFOLIO 220
  • 15.24.3 RECENT DEVELOPMENT 220

16 QUESTIONNAIRE 221

17 RELATED REPORTS 224

LIST OF TABLES

• TABLE 1 NORTH AMERICA FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 59
• TABLE 2 NORTH AMERICA LATERAL FLOW IMMUNO-FOB TEST KITS IN FECAL OCCULT MARKET, BY REGION, 2021-2030 (USD MILLION) 60
• TABLE 3 NORTH AMERICA IMMUNO-FOB AGGLUTINATION TEST KITS IN FECAL OCCULT MARKET, BY REGION, 2021-2030 (USD MILLION) 61
• TABLE 4 NORTH AMERICA IMMUNO-FOB ELISA TEST KITS IN FECAL OCCULT MARKET, BY REGION, 2021-2030 (USD MILLION) 61
• TABLE 5 NORTH AMERICA GUAIAC FOB STOOL TEST IN FECAL OCCULT MARKET, BY REGION, 2021-2030 (USD MILLION) 62
• TABLE 6 NORTH AMERICA GUAIAC FOB STOOL TEST IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 62
• TABLE 7 NORTH AMERICA KITS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 63
• TABLE 8 NORTH AMERICA GUAIAC SLIDES IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 63
• TABLE 9 NORTH AMERICA ALPHA GUAIACONIC ACID (GUAIAC) IMPREGNATED PAPER IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 64
• TABLE 10 NORTH AMERICA SENSITIVITY IS 50NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 64
• TABLE 11 NORTH AMERICA SENSITIVITY IS 75NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 65
• TABLE 12 NORTH AMERICA REAGENTS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 66
• TABLE 13 NORTH AMERICA FLUSHABLE REAGENT PAD OR TISSUE IN FECAL OCCULT MARKET, BY REGION, 2021-2030 (USD MILLION) 67
• TABLE 14 NORTH AMERICA OTHERS IN FECAL OCCULT MARKET, BY REGION, 2021-2030 (USD MILLION) 67
• TABLE 15 NORTH AMERICA FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 71
• TABLE 16 NORTH AMERICA COLORECTAL CANCER SCREENING IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION) 72
• TABLE 17 NORTH AMERICA COLORECTAL CANCER SCREENING IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 72
• TABLE 18 NORTH AMERICA CONCERN FOR GASTROINTESTINAL BLEEDING IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION) 74
• TABLE 19 NORTH AMERICA CONCERN FOR GASTROINTESTINAL BLEEDING IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 74
• TABLE 20 NORTH AMERICA POYLPS IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION) 75
• TABLE 21 NORTH AMERICA POLYPS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 76
• TABLE 22 NORTH AMERICA DIVERTICULOSIS IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION) 77
• TABLE 23 NORTH AMERICA DIVERTICULOSIS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 77
• TABLE 24 NORTH AMERICA ULCERS IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION) 79
• TABLE 25 NORTH AMERICA ULCERS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 79
• TABLE 26 NORTH AMERICA HAEMORRHOIDS IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION) 80
• TABLE 27 NORTH AMERICA HEMORRHOIDS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 81
• TABLE 28 NORTH AMERICA COLITIS IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION) 82
• TABLE 29 NORTH AMERICA COLITIS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 82
• TABLE 30 NORTH AMERICA ANEMIA IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION) 84
• TABLE 31 NORTH AMERICA ANEMIA IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 84
• TABLE 32 NORTH AMERICA OTHERS IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION) 85
• TABLE 33 NORTH AMERICA FECAL OCCULT BLOOD TESTS MARKET, BY END USER, 2021-2030 (USD MILLION) 89
• TABLE 34 NORTH AMERICA DIAGNOSTIC LABORATORIES IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION) 90
• TABLE 35 NORTH AMERICA HOSPITALS IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION) 91
• TABLE 36 NORTH AMERICA SPECIALITY CLINICS IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION) 91
• TABLE 37 NORTH AMERICA OTHERS IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION) 92
• TABLE 38 NORTH AMERICA FECAL OCCULT BLOOD TESTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 96
• TABLE 39 NORTH AMERICA DIRECT TENDER IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION) 97
• TABLE 40 NORTH AMERICA RETAIL SALE IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION) 98
• TABLE 41 NORTH AMERICA RETAIL SALE IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION) 98
• TABLE 42 NORTH AMERICA OTHERS IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION) 99
• TABLE 43 NORTH AMERICA FECAL OCCULT BLOOD TESTS MARKET, BY COUNTRY, 2021-2030 (USD MILLION) 105
• TABLE 44 NORTH AMERICA FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 105
• TABLE 45 NORTH AMERICA FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 105
• TABLE 46 NORTH AMERICA FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 105
• TABLE 47 NORTH AMERICA GUAIAC FOB STOOL TEST IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 106
• TABLE 48 NORTH AMERICA GUAIAC FOB STOOL TEST IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 106
• TABLE 49 NORTH AMERICA GUAIAC FOB STOOL TEST IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 106
• TABLE 50 NORTH AMERICA KITS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 106
• TABLE 51 NORTH AMERICA KITS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 106
• TABLE 52 NORTH AMERICA KITS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 106
• TABLE 53 NORTH AMERICA GUAIAC SLIDES IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 107
• TABLE 54 NORTH AMERICA GUAIAC SLIDES IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 107
• TABLE 55 NORTH AMERICA GUAIAC SLIDES IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 107
• TABLE 56 NORTH AMERICA ALPHA GUAIACONIC ACID (GUAIAC) IMPREGNATED PAPER IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 107
• TABLE 57 NORTH AMERICA ALPHA GUAIACONIC ACID (GUAIAC) IMPREGNATED PAPER IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 107
• TABLE 58 NORTH AMERICA ALPHA GUAIACONIC ACID (GUAIAC) IMPREGNATED PAPER IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 107
• TABLE 59 NORTH AMERICA SENSITIVITY IS 50NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 108
• TABLE 60 NORTH AMERICA SENSITIVITY IS 50NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 108
• TABLE 61 NORTH AMERICA SENSITIVITY IS 50NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 108
• TABLE 62 NORTH AMERICA SENSITIVITY IS 75NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 108
• TABLE 63 NORTH AMERICA SENSITIVITY IS 75NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 108
• TABLE 64 NORTH AMERICA SENSITIVITY IS 75NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 108
• TABLE 65 NORTH AMERICA REAGENTS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 109
• TABLE 66 NORTH AMERICA REAGENTS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 109
• TABLE 67 NORTH AMERICA REAGENTS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 109
• TABLE 68 NORTH AMERICA FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 109
• TABLE 69 NORTH AMERICA COLORECTAL CANCER SCREENING IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 110
• TABLE 70 NORTH AMERICA CONCERN FOR GASTROINTESTINAL BLEEDING IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 110
• TABLE 71 NORTH AMERICA POLYPS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 110
• TABLE 72 NORTH AMERICA DIVERTICULOSIS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 111
• TABLE 73 NORTH AMERICA ULCERS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 111
• TABLE 74 NORTH AMERICA HAEMORRHOIDS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 111
• TABLE 75 NORTH AMERICA COLITIS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 112
• TABLE 76 NORTH AMERICA ANEMIA IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 112
• TABLE 77 NORTH AMERICA FECAL OCCULT BLOOD TESTS MARKET, BY END USER, 2021-2030 (USD MILLION) 112
• TABLE 78 NORTH AMERICA FECAL OCCULT BLOOD TESTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 113
• TABLE 79 U.S. FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 114
• TABLE 80 U.S. FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 114
• TABLE 81 U.S. FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 114
• TABLE 82 U.S. GUAIAC FOB STOOL TEST IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 114
• TABLE 83 U.S. GUAIAC FOB STOOL TEST IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 115
• TABLE 84 U.S. GUAIAC FOB STOOL TEST IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 115
• TABLE 85 U.S. KITS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 115
• TABLE 86 U.S. KITS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 115
• TABLE 87 U.S. KITS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 115
• TABLE 88 U.S. GUAIAC SLIDES IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 115
• TABLE 89 U.S. GUAIAC SLIDES IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 116
• TABLE 90 U.S. GUAIAC SLIDES IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 116
• TABLE 91 U.S. ALPHA GUAIACONIC ACID (GUAIAC) IMPREGNATED PAPER IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 116
• TABLE 92 U.S. ALPHA GUAIACONIC ACID (GUAIAC) IMPREGNATED PAPER IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 116
• TABLE 93 U.S. ALPHA GUAIACONIC ACID (GUAIAC) IMPREGNATED PAPER IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 116
• TABLE 94 U.S. SENSITIVITY IS 50NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 116
• TABLE 95 U.S. SENSITIVITY IS 50NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 117
• TABLE 96 U.S. SENSITIVITY IS 50NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 117
• TABLE 97 U.S. SENSITIVITY IS 75NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 117
• TABLE 98 U.S. SENSITIVITY IS 75NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 117
• TABLE 99 U.S. SENSITIVITY IS 75NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 117
• TABLE 100 U.S. REAGENTS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 117
• TABLE 101 U.S. REAGENTS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 118
• TABLE 102 U.S. REAGENTS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 118
• TABLE 103 U.S. FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 118
• TABLE 104 U.S. COLORECTAL CANCER SCREENING IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 118
• TABLE 105 U.S. CONCERN FOR GASTROINTESTINAL BLEEDING IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 119
• TABLE 106 U.S. POLYPS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 119
• TABLE 107 U.S. DIVERTICULOSIS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 119
• TABLE 108 U.S. ULCERS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 120
• TABLE 109 U.S. HAEMORRHOIDS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 120
• TABLE 110 U.S. COLITIS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 120
• TABLE 111 U.S. ANEMIA IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 121
• TABLE 112 U.S. FECAL OCCULT BLOOD TESTS MARKET, BY END USER, 2021-2030 (USD MILLION) 121
• TABLE 113 U.S. FECAL OCCULT BLOOD TESTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 121
• TABLE 114 CANADA FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 122
• TABLE 115 CANADA FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 122
• TABLE 116 CANADA FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 122
• TABLE 117 CANADA GUAIAC FOB STOOL TEST IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 122
• TABLE 118 CANADA GUAIAC FOB STOOL TEST IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 123
• TABLE 119 CANADA GUAIAC FOB STOOL TEST IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 123
• TABLE 120 CANADA KITS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 123
• TABLE 121 CANADA KITS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 123
• TABLE 122 CANADA KITS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 123
• TABLE 123 CANADA GUAIAC SLIDES IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 123
• TABLE 124 CANADA GUAIAC SLIDES IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 124
• TABLE 125 CANADA GUAIAC SLIDES IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 124
• TABLE 126 CANADA ALPHA GUAIACONIC ACID (GUAIAC) IMPREGNATED PAPER IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 124
• TABLE 127 CANADA ALPHA GUAIACONIC ACID (GUAIAC) IMPREGNATED PAPER IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 124
• TABLE 128 CANADA ALPHA GUAIACONIC ACID (GUAIAC) IMPREGNATED PAPER IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 124
• TABLE 129 CANADA SENSITIVITY IS 50NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 124
• TABLE 130 CANADA SENSITIVITY IS 50NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 125
• TABLE 131 CANADA SENSITIVITY IS 50NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 125
• TABLE 132 CANADA SENSITIVITY IS 75NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 125
• TABLE 133 CANADA SENSITIVITY IS 75NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 125
• TABLE 134 CANADA SENSITIVITY IS 75NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 125
• TABLE 135 CANADA REAGENTS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 125
• TABLE 136 CANADA REAGENTS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 126
• TABLE 137 CANADA REAGENTS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 126
• TABLE 138 CANADA FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 126
• TABLE 139 CANADA COLORECTAL CANCER SCREENING IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 126
• TABLE 140 CANADA CONCERN FOR GASTROINTESTINAL BLEEDING IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 127
• TABLE 141 CANADA POLYPS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 127
• TABLE 142 CANADA DIVERTICULOSIS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 127
• TABLE 143 CANADA ULCERS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 128
• TABLE 144 CANADA HAEMORRHOIDS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 128
• TABLE 145 CANADA COLITIS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 128
• TABLE 146 CANADA ANEMIA IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 129
• TABLE 147 CANADA FECAL OCCULT BLOOD TESTS MARKET, BY END USER, 2021-2030 (USD MILLION) 129
• TABLE 148 CANADA FECAL OCCULT BLOOD TESTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 129
• TABLE 149 MEXICO FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 130
• TABLE 150 MEXICO FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 130
• TABLE 151 MEXICO FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 130
• TABLE 152 MEXICO GUAIAC FOB STOOL TEST IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 130
• TABLE 153 MEXICO GUAIAC FOB STOOL TEST IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 131
• TABLE 154 MEXICO GUAIAC FOB STOOL TEST IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 131
• TABLE 155 MEXICO KITS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 131
• TABLE 156 MEXICO KITS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 131
• TABLE 157 MEXICO KITS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 131
• TABLE 158 MEXICO GUAIAC SLIDES IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 131
• TABLE 159 MEXICO GUAIAC SLIDES IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 132
• TABLE 160 MEXICO GUAIAC SLIDES IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 132
• TABLE 161 MEXICO ALPHA GUAIACONIC ACID (GUAIAC) IMPREGNATED PAPER IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 132
• TABLE 162 MEXICO ALPHA GUAIACONIC ACID (GUAIAC) IMPREGNATED PAPER IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 132
• TABLE 163 MEXICO ALPHA GUAIACONIC ACID (GUAIAC) IMPREGNATED PAPER IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 132
• TABLE 164 MEXICO SENSITIVITY IS 50NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 132
• TABLE 165 MEXICO SENSITIVITY IS 50NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 133
• TABLE 166 MEXICO SENSITIVITY IS 50NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 133
• TABLE 167 MEXICO SENSITIVITY IS 75NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 133
• TABLE 168 MEXICO SENSITIVITY IS 75NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 133
• TABLE 169 MEXICO SENSITIVITY IS 75NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 133
• TABLE 170 MEXICO REAGENTS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 133
• TABLE 171 MEXICO REAGENTS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 134
• TABLE 172 MEXICO REAGENTS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 134
• TABLE 173 MEXICO FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 134
• TABLE 174 MEXICO COLORECTAL CANCER SCREENING IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 134
• TABLE 175 MEXICO CONCERN FOR GASTROINTESTINAL BLEEDING IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 135
• TABLE 176 MEXICO POLYPS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 135
• TABLE 177 MEXICO DIVERTICULOSIS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 135
• TABLE 178 MEXICO ULCERS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 136
• TABLE 179 MEXICO HAEMORRHOIDS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 136
• TABLE 180 MEXICO COLITIS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 136
• TABLE 181 MEXICO ANEMIA IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 137
• TABLE 182 MEXICO FECAL OCCULT BLOOD TESTS MARKET, BY END USER, 2021-2030 (USD MILLION) 137
• TABLE 183 MEXICO FECAL OCCULT BLOOD TESTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 137

LIST OF FIGURES

• FIGURE 1 NORTH AMERICA FECAL OCCULT BLOOD TESTSMARKET: SEGMENTATION 27
• FIGURE 2 NORTH AMERICA FECAL OCCULT BLOOD TESTS MARKET: DATA TRIANGULATION 30
• FIGURE 3 NORTH AMERICA FECAL OCCULT BLOOD TESTS MARKET: DROC ANALYSIS 31
• FIGURE 4 NORTH AMERICA FECAL OCCULT BLOOD TESTS MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS 32
• FIGURE 5 NORTH AMERICA FECAL OCCULT BLOOD TESTS MARKET: COMPANY RESEARCH ANALYSIS 32
• FIGURE 6 NORTH AMERICA FECAL OCCULT BLOOD TESTS MARKET: INTERVIEW DEMOGRAPHICS 33
• FIGURE 7 NORTH AMERICA FECAL OCCULT BLOOD TESTS MARKET: MARKET APPLICATION COVERAGE GRID 35
• FIGURE 8 NORTH AMERICA FECAL OCCULT BLOOD TESTSMARKET: DBMR MARKET POSITION GRID 36
• FIGURE 9 NORTH AMERICA FECAL OCCULT BLOOD TESTS MARKET: VENDOR SHARE ANALYSIS 37
• FIGURE 10 NORTH AMERICA FECAL OCCULT BLOOD TESTS MARKET: SEGMENTATION 40
• FIGURE 11 RISING CASES OF COLORECTAL CANCER NORTH AMERICA AND EASY AVAILABILITY OF FECAL OCCULT IMMUNOLOGICAL TEST DEVICES IN ONLINE STORES ARE EXPECTED TO DRIVE THE GROWTH OF THE NORTH AMERICA FECAL OCCULT BLOOD TESTS MARKET FROM 2023 TO 2030 41
• FIGURE 12 THE LATERAL FLOW IMMUNO-FOB, TEST KITS SEGMENT, IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA FECAL OCCULT BLOOD TESTS MARKET IN 2023 & 2030 41
• FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE NORTH AMERICA FECAL OCCULT BLOOD TESTS MARKET 49
• FIGURE 14 NORTH AMERICA FECAL OCCULT BLOOD TESTS MARKET: BY TEST TYPE, 2022 56
• FIGURE 15 NORTH AMERICA FECAL OCCULT BLOOD TESTS MARKET: BY TEST TYPE, 2023-2030 (USD MILLION) 57
• FIGURE 16 NORTH AMERICA FECAL OCCULT BLOOD TESTS MARKET: BY TEST TYPE, CAGR (2023-2030) 57
• FIGURE 17 NORTH AMERICA FECAL OCCULT BLOOD TESTS MARKET: BY TEST TYPE, LIFELINE CURVE 58
• FIGURE 18 NORTH AMERICA FECAL OCCULT BLOOD TESTS MARKET: BY APPLICATION, 2022 68
• FIGURE 19 NORTH AMERICA FECAL OCCULT BLOOD TESTS MARKET: BY APPLICATION, 2023-2030 (USD MILLION) 69
• FIGURE 20 NORTH AMERICA FECAL OCCULT BLOOD TESTS MARKET: BY APPLICATION, CAGR (2023-2030) 69
• FIGURE 21 NORTH AMERICA FECAL OCCULT BLOOD TESTS MARKET: BY APPLICATION, LIFELINE CURVE 70
• FIGURE 22 NORTH AMERICA FECAL OCCULT BLOOD TESTS MARKET: BY END USER, 2022 86
• FIGURE 23 NORTH AMERICA FECAL OCCULT BLOOD TESTS MARKET: BY END USER, 2023-2030 (USD MILLION) 87
• FIGURE 24 NORTH AMERICA FECAL OCCULT BLOOD TESTS MARKET: BY END USER, CAGR (2023-2030) 87
• FIGURE 25 NORTH AMERICA FECAL OCCULT BLOOD TESTS MARKET : BY END USER, LIFELINE CURVE 88
• FIGURE 26 NORTH AMERICA FECAL OCCULT BLOOD TESTS MARKET : BY DISTRIBUTION CHANNEL, 2022 93
• FIGURE 27 NORTH AMERICA FECAL OCCULT BLOOD TESTS MARKET : BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 94
• FIGURE 28 NORTH AMERICA FECAL OCCULT BLOOD TESTS MARKET : BY DISTRIBUTION CHANNEL, CAGR (2023-2030) 94
• FIGURE 29 NORTH AMERICA FECAL OCCULT BLOOD TESTS MARKET : BY DISTRIBUTION CHANNEL, LIFELINE CURVE 95
• FIGURE 30 NORTH AMERICA FECAL OCCULT BLOOD TESTS MARKET: SNAPSHOT (2022) 101
• FIGURE 31 NORTH AMERICA FECAL OCCULT BLOOD TESTS MARKET: BY COUNTRY (2022) 102
• FIGURE 32 NORTH AMERICA FECAL OCCULT BLOOD TESTS MARKET: BY COUNTRY (2023 & 2030) 102
• FIGURE 33 NORTH AMERICA FECAL OCCULT BLOOD TESTS MARKET: BY COUNTRY (2023 & 2030) 103
• FIGURE 34 NORTH AMERICA FECAL OCCULT BLOOD TESTS MARKET: BY TEST TYPE (2023-2030) 103
• FIGURE 35 NORTH AMERICA FECAL OCCULT BLOOD TESTS MARKET: COMPANY SHARE 2022 (%) 137